Abstract
Genes encoding membrane proteins comprise a substantial proportion of genomes sequenced to date, but ability to perform structural studies on this portion of the proteome is limited. Electrospray ionization-MS (ESI-MS) of an intact protein generates a profile defining the native covalent state of the gene product and its heterogeneity. Here we apply ESI-MS technology with accuracy exceeding 0.01% to a hydrophobic membrane protein with 12-transmembrane α-helices, the full-length lactose permease from Escherichia coli. Furthermore, ESI-MS is used to titrate reactive thiols with N-ethylmaleimide. Treatment of the native protein solubilized in detergent micelles reveals only two reactive thiols, and both are protected by a substrate analog.
Of the genomes sequenced thus far, 35% of the gene products are known or predicted to be polytopic transmembrane proteins. These proteins catalyze a multitude of essential functions, from oxidative phosphorylation and electron transfer to transport of molecules in and out of cells to signal transduction across membranes to bacterial motility. Many are important with regard to human disease (e.g., cystic fibrosis), and at least two of the most widely prescribed drugs in the U.S., Prozac and Prilosec, are targeted to membrane transport proteins. Although advances in molecular biology and biochemistry over the last 15 years have led to the characterization, purification, and modification of this class of proteins, only a handful have been crystallized in a form allowing for structure determination at atomic resolution that is essential for understanding mechanism of action. Furthermore, many membrane proteins require conformational flexibility to function, making it imperative to obtain dynamic information to fully understand function.
Unfortunately, protein primary structure predicted from gene sequencing is biased because of sequencing errors, RNA editing, and alternative splicing, as well as a range of posttranslational modifications that often play essential roles in function. One way to monitor the proteome is through use of MS (1). The electrospray ionization-MS (ESI-MS) of an intact protein provides a unique image of native covalent state and heterogeneity, because of the accuracy and resolution of the technique (2–5). The measured mass sometimes agrees with the theoretical mass based on the gene sequence, but most often demands modification of the predicted structure until coincidence is achieved. Thus, in a first step to obtain proteomic information, the native mass of a protein is a vital statistic, but is found only in a few database entries. In this study, size-exclusion HPLC in acidic aqueous chloroform/methanol is coupled with online ESI-MS (size exclusion chromatography-MS) to obtain the mass spectrum of a 12-transmembrane helix transport protein, the lactose permease of Escherichia coli.
Lactose permease is a paradigm for secondary active transport proteins that convert the free energy stored in an electrochemical proton gradient into work in the form of a solute concentration gradient (6). The lacY gene has been cloned and sequenced, and each residue has been mutagenized. The permease has been overexpressed, purified, reconstituted into proteoliposomes, and shown to be active as a monomer. A battery of site-directed techniques has been developed to determine helix packing and the relationship between the six irreplacable amino acid side chains in the molecule (7). In addition, two-dimensional crystallography, attenuated total reflection-Fourier transform IR spectroscopy, and other biophysical studies indicate that the protein is loosely arranged to form a central aqueous pore that presumably represents the translocation pathway (8–10). However, the recombinant protein used for structural analyses has not been studied with respect to covalent structure or the occurrence of noncovalent, tightly bound lipids.
MATERIALS AND METHODS
Cell Growth, Membrane Preparation, and Purification of Native Permease.
E. coli XL 1 blue was grown in fermentors by using enriched LB medium (90 g tryptone, 90 g NaCl, 45 g of yeast extract, 35 g KH2PO4, 50 g K2HPO4, trace metals in 10 liters of water). The fermentors were inoculated with an overnight culture of freshly transformed cells bearing the PTC189 + 6His417 expression vector encoding wild-type lacY with a C-terminal 6-His affinity tag. Cells were induced with 1 mM isopropyl β-d-thiogalactoside at OD600 1.0 and harvested at an OD of approximately 2.0. Concentrated cells were washed once in cold 50 mM KPi (pH 7.5) and a second time in the same buffer plus 10 mM MgSO4. To prepare membranes, cells were resuspended in cold, 50 mM KPi (pH 7.5), 10 mM MgSO4, 0.5 mM Pefabloc, 10 mM β-mercaptoethanol (BME), and 30 μg/ml DNase. Cells were broken by using two consecutive passes through an Emulsiflex (Avestin, Ottawa, Canada) homogenizer (15,000–20,000 psi) and unbroken cells were removed by centrifugation (15 min at 10,000 × g). A membrane fraction was obtained from the supernatant by centrifugation (2 h at 150,000 × g). To remove peripheral membrane proteins, the membrane fraction was washed with urea (5 M urea, 50 mM KPi, pH 7.5, 0.5 mM Pefabloc, 10 mM BME), stirred for 30 min on ice, and centrifuged for 2 h at 170,000 × g. The supernatant was discarded, and the membranes were resuspended in cold 50 mM KPi (pH 7.2), 0.2 M NaCl, 10 mM BME, 0.25 mg/ml phospholipid (phosphatidylethanolamine/phosphatidylglycerol; 3:1, wt/wt) (1.0 ml buffer/g cells), and n-dodecyl-β-d-maltoside (DDM) was added to a final concentration of 2% while stirring on ice for 45 min. After removing insoluble material by centrifugation at 150,000 × g for 30 min, the supernatant was combined with washed Ni/nitrilotriacetic acid resin (Qiagen, Chatsworth, CA) (0.35 ml of resin/1.0 g of cells) and rotated for 2 h at 4°C. Using a glass column, the loaded Ni resin was washed thoroughly with 50 mM KPi (pH 7.2), 10% glycerol, 0.16% DDM, and subsequently with up to 50 mM imidazole in the same buffer. The protein was eluted upon increasing the concentration of imidazole to 200 mM and dialyzed overnight against 50 mM KPi (pH 7.5), 0.016% DDM, 1 mM EDTA. A recombinant form of the permease containing cytochrome b562 fused into the middle cytoplasmic loop and named “red” permease was purified with a similar protocol.
Sample Preparation for MS.
All permease samples used for MS experiments displayed substrate binding activity by flow dialysis (28). Typically, aliquots of permease in detergent suspension were precipitated with CHCl3/MeOH, essentially as described by Wessel and Flügge (29). An aliquot (100 μl) of the aqueous protein solution at 1–2 mg/ml protein was diluted 1:3 (vol/vol) with MeOH and mixed briefly. CHCl3 (100 μl) was added, and mixing yielded a single phase. Phase separation was initiated by addition of water (200 μl) and vigorous mixing. The phases were separated by centrifugation (10,000 × g, for 2 min), yielding precipitated protein at the interface. The bulk of the upper aqueous methanol phase then was removed, and methanol (300 μl) was added. After mixing, the pellet remained insoluble in a single-phase mixture before it was recovered by centrifugation (10,000 × g, 1 min). The pellet was dried for 1–2 min with the tube inverted before dissolving the sample in 50 μl of 90% formic acid. Samples were subjected immediately to HPLC. For labeling with N-ethylmaleimide (NEM) the native, solubilized protein was incubated at a final concentration of 1 mM with NEM, and the reaction was terminated by addition of DTT to a final concentration of 10 mM.
HPLC Chromatography.
For final purification, HPLC was used before ESI-MS in an in-line setup. The “white” permease was purified by using isocratic elution (0.5 ml/min), with a size exclusion column (G2000SW, TosoHaas, Montgomeryville, PA, 10 μM, 300 × 7.8 mm) in an aqueous organic solvent mixture (30). A mixture of degassed CHCl3/MeOH/1% aqueous formic acid (4:4:1; vol/vol) was used as solvent. The column was equilibrated extensively and tested with blank injections of 90% formic acid before experiments. For “red” permease, a polystyrene/divinylbenzene column (PLRP/S, Polymer Labs, Amherst, MA) was substituted. Separations were performed at 40°C by using a modified ABI120A dual syringe pump machine equipped with a postdetector splitter for back-pressure regulation and fraction collection.
ESI-MS.
ESI-MS analysis was performed by using a Perkin–Elmer Sciex API III+ triple quadrupole instrument operating in positive ion mode as described (2). An orifice potential of 75 V was found optimal for E. coli lactose permease.
RESULTS AND DISCUSSION
To achieve mass spectrometric analysis of a membrane protein, it is necessary to remove detergents and lipids used for solubilization (11–17). Chloroform/methanol/water phase separation was used to precipitate the permease, thereby removing detergent and residual phospholipid. The aggregated pellet can be dissolved in 90% formic acid, but is still accompanied by tightly bound lipids and residual detergent requiring further purification of the polypeptide before ionization. Because a single-phase mixture of chloroform/methanol/1% aqueous formic acid (4:4:1, vol/vol) effectively solubilizes certain intrinsic membrane proteins (18), the permease was transferred to this solvent mixture by using size-exclusion chromatography (Fig. 1). Both the UV and the total ion chromatogram show separation of material, which is not visualized by SDS/PAGE. On-line ESI-MS of the permease peak reveals a clean spectrum (Fig. 2) with an excellent signal-to-noise ratio.
The acidified aqueous organic solvent mixture is highly compatible with electrospray ionization, and permease ions carrying from 20 to 50 positive charges (H+) are detected (Fig. 2). The ions fall into three distinct classes, which may indicate different conformational states in the gas phase (19). Stable elements of secondary and tertiary structure have been observed for some membrane proteins in aqueous organic solvent mixtures (20). The molecular weight reconstruction of the uncharged permease with a 6-His tag (Fig. 2, Inset) reveals that the lacY gene product is homogeneous and that the computed mass (47,357) is within 0.01% of that calculated from the DNA sequence with a formyl group on the initiating methionine (Table 1). Previous studies (21) show that the formyl group is removed from native permease but overexpression may overwhelm deformylase activity. Importantly, the MS spectra indicate formylation when the protein is solubilized in trifluororacetic acid (not shown), and a recombinant form of the permease containing cytochrome b562 fused into the middle cytoplasmic loop (22, 23) also is formylated. Finally the protein is amenable to Edman degradation only after N-terminal deblocking.
Table 1.
E. coli lactose permease | Calculated mass,‡ Da | Measured mass, Da | Difference (%) |
---|---|---|---|
Native (+6 His tag)* | 47,354 | 47,357 | (<0.01) |
“Red” (+10 His tag)† | 60,458 | 60,457 | (<0.01) |
Native lactose permease sequence with a six-His tag and N-formylation of Met1.
Permease construct with cytochrome b562 in the middle cytoplasmic loop, a 10-His tag at the C terminus and N-formylation of Met1.
Average masses are used based on natural isotopic abundance.
MS has the power to monitor subtle covalent modifications that often modulate regulatory and functional plasticity (2, 24–26), and it is possible to observe chemical modifications with unprecedented detail. To probe the eight native Cys residues in lactose permease, the protein was alkylated with N-ethylmaleimide in the presence or absence of the substrate analog d-galactopyranosyl β-d-thio-galactopyranoside (TDG) (Fig. 3). Although none of the thiols are involved in disulfide bonds, ESI-MS demonstrates that only two are alkylated (each NEM addition increases the mass by 125 Da), and slowing of the reaction indicates different reaction rates for each thiol (Fig. 3B). Substrate-protected NEM labeling of only two native Cys residues, Cys-148 and Cys-355, has been described (7). ESI-MS detects a dominant amount of material that remains unmodified or labeled with only one NEM when the reaction is performed in the presence of TDG (Fig. 3D), demonstrating that one of the Cys residues is only partially protected by substrate. Labeling of Cys-148, a component of the binding site that interacts hydrophobically with the galactosyl moiety of the substrate, is inhibited completely by substrate. On the other hand, substrate protection of Cys-355 against alkylation reflects a long-range conformational change caused by binding of substrate (7).
It is demonstrated here that large hydrophobic intrinsic membrane proteins are completely amenable to mass spectrometric analysis. MS will play a vital role in proteomics with ionization of intact proteins increasingly becoming an alternative to working with peptide fragments (27). Combination of ESI-MS with suitable chromatography should allow rapid analysis of complex protein mixtures such as entire membrane fractions with high accuracy within less than 1 hr.
Acknowledgments
The W.M. Keck Foundation provided support toward instrument purchase. The work was also supported in part by National Institutes of Health Grant R01 DK51131-01 (to H.R.K.). G.G.P. is supported by a Grant from the Medical Research Council of Canada. C.K.E. is a postdoctoral fellow of the Deutsche Forschungsgemeinschaft.
ABBREVIATIONS
- ESI-MS
electrospray ionization-MS
- NEM
N-ethylmaleimide
References
- 1.Lander E S. Science. 1996;274:536–539. doi: 10.1126/science.274.5287.536. [DOI] [PubMed] [Google Scholar]
- 2.Whitelegge J P, Gundersen C B, Faull K F. Protein Sci. 1998;7:1423–1430. doi: 10.1002/pro.5560070619. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Ashton D S, Beddell C R, Green B N, Oliver R W. FEBS Lett. 1994;342:1–6. doi: 10.1016/0014-5793(94)80572-5. [DOI] [PubMed] [Google Scholar]
- 4.Fenn J B, Mann M, Meng C K, Wong S F, Whitehouse C M. Science. 1989;246:64–71. doi: 10.1126/science.2675315. [DOI] [PubMed] [Google Scholar]
- 5.Covey T R, Bonner R F, Shushan B I, Henion J. Rapid Commun Mass Spectrom. 1988;2:249–256. doi: 10.1002/rcm.1290021111. [DOI] [PubMed] [Google Scholar]
- 6.Kaback H R. J Cell Physiol. 1976;89:575–593. doi: 10.1002/jcp.1040890414. [DOI] [PubMed] [Google Scholar]
- 7.Frillingos S, Sahin-Tóth M, Wu J, Kaback H R. FASEB J. 1998;12:1281–1299. doi: 10.1096/fasebj.12.13.1281. [DOI] [PubMed] [Google Scholar]
- 8.Zhuang J, Privé G G, Verner G E, Ringler P, Kaback H R, Engel A. J Struct Biol. 1999;125:63–75. doi: 10.1006/jsbi.1998.4059. [DOI] [PubMed] [Google Scholar]
- 9.le Coutre J, Narasimhan L R, Patel C K, Kaback H R. Proc Natl Acad Sci USA. 1997;94:10167–10171. doi: 10.1073/pnas.94.19.10167. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.le Coutre J, Kaback H R, Patel C K N, Heginbotham L, Miller C. Proc Natl Acad Sci USA. 1998;95:6114–6117. doi: 10.1073/pnas.95.11.6114. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Bouchon B, Van Dorsselaer A, Roitsch C. Biol Mass Spectrom. 1993;22:358–360. doi: 10.1002/bms.1200220608. [DOI] [PubMed] [Google Scholar]
- 12.Hufnagel P, Schweiger U, Eckerskorn C, Oesterhelt D. Anal Biochem. 1996;243:46–54. doi: 10.1006/abio.1996.0480. [DOI] [PubMed] [Google Scholar]
- 13.le Maire M, Deschamps S, Møller J V, Le Caer J P, Rossier J. Anal Biochem. 1993;214:50–57. doi: 10.1006/abio.1993.1455. [DOI] [PubMed] [Google Scholar]
- 14.Rosinke B, Strupat K, Hillenkamp F, Rosenbusch J, Dencher N, Kruger U, Galla H J. J Mass Spectrom. 1995;30:1462–1468. [Google Scholar]
- 15.Schaller J, Pellascio B C, Schlunegger U P. Rapid Commun Mass Spectrom. 1997;11:418–426. [Google Scholar]
- 16.Schindler P A, Van Dorsselaer A, Falick A M. Anal Biochem. 1993;213:256–263. doi: 10.1006/abio.1993.1418. [DOI] [PubMed] [Google Scholar]
- 17.Barnidge D R, Dratz E A, Jesaitis A J, Sunner J. Anal Biochem. 1999;269:1–9. doi: 10.1006/abio.1999.4012. [DOI] [PubMed] [Google Scholar]
- 18.Fearnley I M, Walker J E. Biochem Soc Trans. 1996;24:912–917. doi: 10.1042/bst0240912. [DOI] [PubMed] [Google Scholar]
- 19.Konermann L, Douglas D J. Biochemistry. 1997;36:12296–12302. doi: 10.1021/bi971266u. [DOI] [PubMed] [Google Scholar]
- 20.Arkin I T, Russ W P, Lebendiker M, Schuldiner S. Biochemistry. 1996;35:7233–7238. doi: 10.1021/bi960094i. [DOI] [PubMed] [Google Scholar]
- 21.Ehring R, Beyreuther K, Wright J K, Overath P. Nature (London) 1980;283:537–540. doi: 10.1038/283537a0. [DOI] [PubMed] [Google Scholar]
- 22.Privé G G, Verner G E, Weitzman C, Zen K H, Eisenberg D, Kaback H R. Acta Crystrallogr. 1994;50:375–379. doi: 10.1107/S0907444993014301. [DOI] [PubMed] [Google Scholar]
- 23.Privé G G, Kaback H R. J Bioenerg Biomembr. 1996;28:29–34. [PubMed] [Google Scholar]
- 24.Burlingame A L, Boyd R K, Gaskell S J. Anal Chem. 1996;68:599R–651R. doi: 10.1021/a1960021u. [DOI] [PubMed] [Google Scholar]
- 25.Chait B T, Kent S B. Science. 1992;257:1885–1894. doi: 10.1126/science.1411504. [DOI] [PubMed] [Google Scholar]
- 26.Roepstorff P. Curr Opin Biotechnol. 1997;8:6–13. doi: 10.1016/s0958-1669(97)80151-6. [DOI] [PubMed] [Google Scholar]
- 27.McLafferty F W, Kelleher N L, Begley T P, Fridriksson E K, Zubarev R A, Horn D M. Curr Opin Chem Biol. 1998;2:571–578. doi: 10.1016/s1367-5931(98)80085-9. [DOI] [PubMed] [Google Scholar]
- 28.Sahin-Tóth M, le Coutre J, Kharabi D, le Maire G, Lee J C, Kaback H R. Biochemistry. 1999;38:813–819. doi: 10.1021/bi982200h. [DOI] [PubMed] [Google Scholar]
- 29.Wessel D, Flügge U I. Anal Biochem. 1984;138:141–143. doi: 10.1016/0003-2697(84)90782-6. [DOI] [PubMed] [Google Scholar]
- 30.Whitelegge J P, Jewess P, Pickering M G, Gerrish C, Camilleri P, Bowyer J R. Eur J Biochem. 1992;207:1077–1084. doi: 10.1111/j.1432-1033.1992.tb17144.x. [DOI] [PubMed] [Google Scholar]